Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell Transplantation.

导出 LinkOut

翻译打印收藏纠错

作者： Yin,Liu ^[1] ; Yi,Fan ^[1] ; Wenli,Zhang ^[2] ; Jia,Chen ^[1] ; Qiao,Cheng ^[1] ; Xiao,Ma ^[3] ; Zhihong,Lin ^[4] ; Depei,Wu ^[5] ; Yang,Xu ^[6]

作者单位： National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. ^[1] Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. ^[2] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, China; Soochow Hopes Hematonosis Hospital, Suzhou, China. ^[3] Soochow Yongding Hospital, Department of Affiliated Renji Hospital of Shanghai Jiao Tong University of Medicine, Suzhou, China. ^[4] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. Electronic address: drwudepei@163.com. ^[5] National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. Electronic address: yangxu@suda.edu.cn. ^[6]

关键词 Beijing Protocol Haplo-SCT JAK inhibitor Ruxolitinib Steroid-refractory GVHD

主题词移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);腈类(Nitriles);吡唑类(Pyrazoles);嘧啶类(Pyrimidines);回顾性研究(Retrospective Studies);挽救疗法(Salvage Therapy);甾类(Steroids)

DOI 10.1016/j.jtct.2021.01.019

PMID 33836880

发布时间 2021-12-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Transplantation and cellular therapy

2021年27卷4期

332.e1-332.e8页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell Transplantation.

Transplantation and cellular therapy

相似文献

Transplantation and cellular therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell Transplantation.

Transplantation and cellular therapy

相似文献

Transplantation and cellular therapy

相关期刊

检索历史清除